Emery, Paul
Article History
First Online: 23 December 2014
Competing interests
: The author declares that he has undertaken clinical trials and acted as a consultant for Abbott/Abbvie, Bristol Myers Squibb, Lilly, MSD, Novartis, Pfizer, Roche, Samsung, Takeda and UCB.